Multimodal neural correlates of childhood psychopathology
Abstract
Complex structural and functional changes occurring in typical and atypical development necessitate multidimensional approaches to better understand the risk of developing psychopathology. Here, we simultaneously examined structural and functional brain network patterns in relation to dimensions of psychopathology in the Adolescent Brain Cognitive Development dataset. Several components were identified, recapitulating the psychopathology hierarchy, with the general psychopathology (p) factor explaining most covariance with multimodal imaging features, while the internalizing, externalizing, and neurodevelopmental dimensions were each associated with distinct morphological and functional connectivity signatures. Connectivity signatures associated with the p factor and neurodevelopmental dimensions followed the sensory-to-transmodal axis of cortical organization, which is related to the emergence of complex cognition and risk for psychopathology. Results were consistent in two separate data subsamples and robust to variations in analytical parameters. Although model parameters yielded statistically significant brain-behavior associations in unseen data, generalizability of the model was rather limited for all three latent components (r change from within- to out-of-sample statistics: LC1within=0.36, LC1out=0.03; LC2within=0.34, LC2out=0.05; LC3within=0.35, LC3out=0.07). Our findings help in better understanding biological mechanisms underpinning dimensions of psychopathology, and could provide brain-based vulnerability markers.
Data availability
The ABCD data are publicly available via the NIMH Data Archive (https://nda.nih.gov/abcd/).The preprocessing pipeline can be found at https://github.com/ThomasYeoLab/CBIG/tree/master/stable_projects/preprocessing/CBIG_fMRI_Preproc2016.Preprocessing code specific to this study can be found here: https://github.com/ThomasYeoLab/ABCD_scripts.The code for analyses can be found here: (https://github.com/valkebets/multimodal_psychopathology_components).
Article and author information
Author details
Funding
NUS Yong Loo Lin School of Medicine (NUHSRO/2020/124/TMR/LOA)
- BT Thomas Yeo
Singapore National Medical Research Council (OFLCG19May-0035; CTGIIT23jan-0001; OFIRG24jan-0030; STaR20nov-0003)
- BT Thomas Yeo
Singapore Ministry of Health (CG21APR1009)
- BT Thomas Yeo
Temasek Foundation (TF2223-IMH-01)
- BT Thomas Yeo
National Institutes of Health (R01MH133334)
- BT Thomas Yeo
Natural Sciences and Engineering Research Council of Canada (NSERC Discovery-1304413)
- Boris C Bernhardt
Canadian Institutes of Health Research (FDN-154298; PJT-174995)
- Boris C Bernhardt
Sick Kids Foundation (NI17-039)
- Boris C Bernhardt
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: Ethical review and approval of the protocol was obtained from the Institutional Review Board (IRB) at the University of California, San Diego, as well as from local IRB (Auchter et al., 2018; https://doi.org/10.1016/j.dcn.2018.04.003). Parents/guardians and children provided written assent (Clark et al., 2018; https://doi.org/10.1016/j.dcn.2017.06.005).
Copyright
© 2024, Royer et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 555
- views
-
- 91
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Medicine
- Neuroscience
Monomethyl fumarate (MMF) and its prodrug dimethyl fumarate (DMF) are currently the most widely used agents for the treatment of multiple sclerosis (MS). However, not all patients benefit from DMF. We hypothesized that the variable response of patients may be due to their diet. In support of this hypothesis, mice subjected to experimental autoimmune encephalomyelitis (EAE), a model of MS, did not benefit from DMF treatment when fed a lauric acid-rich (LA) diet. Mice on normal chow (NC) diet, in contrast, and even more so mice on high-fiber (HFb) diet showed the expected protective DMF effect. DMF lacked efficacy in the LA diet-fed group despite similar resorption and preserved effects on plasma lipids. When mice were fed the permissive HFb diet, the protective effect of DMF treatment depended on hydroxycarboxylic receptor 2 (HCAR2) which is highly expressed in neutrophil granulocytes. Indeed, deletion of Hcar2 in neutrophils abrogated DMF protective effects in EAE. Diet had a profound effect on the transcriptional profile of neutrophils and modulated their response to MMF. In summary, DMF required HCAR2 on neutrophils as well as permissive dietary effects for its therapeutic action. Translating the dietary intervention into the clinic may improve MS therapy.
-
- Neuroscience
Aβ is believed to play a significant role in synaptic degeneration observed in Alzheimer’s disease and is primarily investigated as a secreted peptide. However, the contribution of intracellular Aβ or other cleavage products of its precursor protein (APP) to synaptic loss remains uncertain. In this study, we conducted a systematic examination of their cell-autonomous impact using a sparse expression system in rat hippocampal slice culture. Here, these proteins/peptides were overexpressed in a single neuron, surrounded by thousands of untransfected neurons. Surprisingly, we found that APP induced dendritic spine loss only when co-expressed with BACE1. This effect was mediated by β-CTF, a β-cleavage product of APP, through an endosome-related pathway independent of Aβ. Neuronal expression of β-CTF in mouse brains resulted in defective synaptic transmission and cognitive impairments, even in the absence of amyloid plaques. These findings unveil a β-CTF-initiated mechanism driving synaptic toxicity irrespective of amyloid plaque formation and suggest a potential intervention by inhibiting the endosomal GTPase Rab5.